Sh Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 01-01-2025
- Paid Up Capital ₹ 1.27 Cr
as on 01-01-2025
- Company Age 29 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 01-01-2025
- Satisfied Charges ₹ 2.50 M
as on 01-01-2025
- Revenue 13.25%
(FY 2022)
- Profit 150.91%
(FY 2022)
- Ebitda 21.75%
(FY 2022)
- Net Worth 75.54%
(FY 2022)
- Total Assets 6.06%
(FY 2022)
About Sh Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.27 Cr.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Reddy, Bala Bhaskar, Aditya Reddy, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230TG1995PLC021887
- Company No.
021887
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
29 Sep 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sh Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Reddy  | Director | 16-Oct-2020 | Current |
| Sanjay Reddy | Director | 10-May-2005 | Current |
| Bala Bhaskar | Additional Director | 28-Aug-2008 | Current |
| Sudhakar Malisetti | Director | 10-May-2005 | Current |
Financial Performance of Sh Pharmaceuticals.
Sh Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.25% increase. The company also saw a substantial improvement in profitability, with a 150.91% increase in profit. The company's net worth Soared by an impressive increase of 75.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sh Pharmaceuticals?
In 2022, Sh Pharmaceuticals had a promoter holding of 99.96% and a public holding of 0.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Deepaditya Developers India LlpActive 9 years 6 monthsSanjay Reddy and Aditya Reddy are mutual person
- Epsi Building Management Services LlpActive 8 years 5 months
Sanjay Reddy and Aditya Reddy are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 May 2013 | ₹1.50 Cr | Open |
State Bank Of India Creation Date: 06 Mar 2009 | ₹2.50 M | Satisfied |
How Many Employees Work at Sh Pharmaceuticals?
Sh Pharmaceuticals has a workforce of 164 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sh Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sh Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
